Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating stroke

A composition and drug technology, applied in the direction of drug combination, active ingredients of hydroxyl compounds, pharmaceutical formulations, etc., can solve the problems of high price of traditional Chinese medicine, single dosage form, good stroke effect, etc., to restore nerve circulation, promote blood relaxation, and resolve The effect of thrombus obstruction

Inactive Publication Date: 2014-12-17
李绍华
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, the Chinese Patent Publication No. is CN103223121A, which discloses a stroke hemiplegia pill, a treatment for stroke hemiplegia, selected from: ground turtle, scorpion, earthworm, gastrodia elata, uncaria, aconite, water frog, araceae, pinellia, safflower, white flower Composition of snake, centipede, calamus calamus, and cassia chinensis, the above-mentioned medicines are put in according to the weight ratio of the prescription, crushed into fine powder (120 mesh), and made into honeyed pills according to the preparation method of traditional Chinese medicine pills, each pill weighs 9g, but there is a single dosage form The problem
At present, the effect of traditional Chinese medicine on stroke is less effective, and the price of some traditional Chinese medicine is higher

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating stroke
  • Pharmaceutical composition for treating stroke
  • Pharmaceutical composition for treating stroke

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041]

[0042] Weigh the above raw materials according to the ratio, add water to decoct twice, add 7 times the amount of water for the first time, decoct for 1.5 hours, add 8 times the amount of water for the second time, decoct for 1.5 hours, combine the decoction, filter, and filtrate The extract concentrated to a relative density of 1.30 (measured at 70° C.) is added with a conventional amount of dextrin auxiliary material, and made into capsules according to a conventional process, 0.5 g / capsule.

Embodiment 2

[0044]

[0045] Weigh the above raw materials according to the ratio, add water to decoct twice, add 7 times the amount of water for the first time, decoct for 1.5 hours, add 8 times the amount of water for the second time, decoct for 1.5 hours, combine the decoction, filter, and filtrate Concentrate the extract to a relative density of 1.30 (measured at 70°C), add an appropriate amount of sucrose powder, and make granules according to a conventional process.

Embodiment 3

[0047]

[0048] Weigh the above raw materials, add water to decoct twice, add 8 times the amount of water for the first time, decoct for 2 hours, add 6 times the amount of water for the second time, decoct for 1.5 hours, combine the decoctions, filter to obtain a decoction.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating stroke. By weight, the pharmaceutical composition is composed of the following active ingredients: 12-24 parts of Angelica dahurica, 12-24 parts of Ligusticum wallichii, 12-24 parts of Asarum sieboldii, 12-24 parts of cimicifugae foetidae, 12-24 parts of gastrodia elata, 12-24 parts of fleece-flower roots, 12-24 parts of Uncaria tomentosa, 12-24 parts of scorpio, 12-24 parts of lumbricus, 9-21 parts of Salvia miltiorrhiza, 9-21 parts of radix sileris, 9-21 parts of Angelica sinensis, 9-21 parts of Carthamus tinctorius, 9-21 parts of Panax notoginseng, 9-21 parts of borneol, 9-21 parts of saponin, 9-21 parts of fructus cannabis, 9-21 parts of chastetree fruit, 9-21 parts of white mustard seeds and 9-21 parts of lycopodium clavatum. The pharmaceutical composition for treating stroke can overcome shortcomings of the existing medicine for treating stroke and is good in the curative effect.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating stroke. Background technique [0002] Currently in life, stroke is at a stage of high incidence, and stroke is one of the three major causes of death (stroke, heart disease and cancer) among the elderly today. Stroke can be divided into two categories: ischemic stroke and hemorrhagic stroke. With the changes in lifestyle and work patterns, stroke has become a disease with a high incidence rate. Stroke is an acute or subacute disease caused by cerebrovascular disease. Obscurity, hemiplegia, etc. are the main manifestations of a lesion. More common in the elderly, especially those with high blood pressure or significant arteriosclerosis. Often feel head buzzing, dizziness, numb face and mouth, drowsiness, abnormal personality, irritability, unable to move fingers apart, arm numbness, pain, etc. These are the main sym...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8988A61P9/10A61P25/06A61P25/28A61K35/64A61K35/56A61K31/045
Inventor 李绍华
Owner 李绍华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products